It appears a trial of cannabis-based medicine to be used with Tourette Syndrome patients in Australia has made a start.Tourette Syndrome, which develops in...
Australia's Medlab (ASX: MDC) last week announced an agreement with Arrotex concerning the development and distribution of Medlab's NanoCBD cannabinoid formulation.NanoCBD contains 16.67 mg/mL...
Another one - MediPharm Labs Australia Pty. Ltd. has received a cannabis manufacturing licence from Australia's Office of Drug Control.The firm is a subsidiary...